ETRACS 2x Leveraged MSCI US Quality Factor TR ETN
QULL
1 hedge funds and large institutions have $316K invested in ETRACS 2x Leveraged MSCI US Quality Factor TR ETN in 2023 Q1 according to their latest regulatory filings, with 0 funds opening new positions, increasing their positions, 1 reducing their positions, and 1 closing their positions.
16% more capital invested
Capital invested by funds: $272K → $316K (+$43.6K)
0.01% less ownership
Funds ownership: 1.23% → 1.22% (-0.01%)
50% less funds holding
Funds holding: 2 → 1 (-1)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 1
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
-$1.04K |
| 2 |
IMC Chicago
Chicago,
Illinois
|
-$73 |
QULL Hedge Fund Activity: Q1 2023 in Review
1 of the 6,276 institutional investors tracked by Wall St. Rank reported a position in ETRACS 2x Leveraged MSCI US Quality Factor TR ETN (QULL) for Q1 2023, worth a combined $316K — up 16% from $272K a quarter earlier.
Sellers outnumbered buyers: 1 fund closed out of QULL and 0 opened new positions — a net loss of 1 holder — while 1 trimmed existing stakes and 0 added.
The largest seller was UBS Group, exiting entirely with an estimated $1.04K sold.
- 1 institutional investor held ETRACS 2x Leveraged MSCI US Quality Factor TR ETN (QULL) as of Q1 2023, down from 2 in Q4 2022.
- Funds reported $316K of ETRACS 2x Leveraged MSCI US Quality Factor TR ETN stock for Q1 2023, up 16% quarter-over-quarter.
- 0 funds opened new ETRACS 2x Leveraged MSCI US Quality Factor TR ETN positions in Q1 2023 and 1 closed out, a net change of -1 holder.
- The largest ETRACS 2x Leveraged MSCI US Quality Factor TR ETN seller in Q1 2023 was UBS Group, an estimated $1.04K sold.
Based on aggregated 13F filings for Q1 2023.